-The Hindu Cabinet announces relief, rules out MSP HUBBALLI (Karnataka): The State Cabinet on Wednesday ruled out the possibility of a minimum support price (MSP) for onion while announcing a compensation of Rs. 9,000 a hectare for crops damaged due to rains in Chitradurga, Davangere, Gadag, Dharwad and Bellary districts. This has come on the heels of growers protesting crashing prices of their produce. A macro view of market scenario shows that fluctuations...

-Down to Earth Agricultural markets have turned into centres of political power, say farmers' organisations The new BJP government in Maharashtra has dismissed 166 agricultural produce market committees (APMCs), including the apex Navi Mumbai APMC, following thousands of complaints of irregularities and misconduct received against them. An order to this effect was issued on Monday, November 10, to the director of agricultural marketing in the state. Agriculture Secretary Sudhir Goyal informed that the...

-The Telegraph Bhagalpur: The state government has urged Bihar Agriculture University (BAU), Sabour, and Rajendra Agriculture University (RAU), Pusa, to spread community radio network in their respective areas. At a time when Prime Minister Narendra Modi himself connects with India over radio now and then, the state government's effort goes to show how radio remains indispensable for the common man. The state government's effort would help update farmers with agricultural practices by adopting...

-The Hindu It will be tabled in the winter session of the legislature Bengaluru (Karnataka): To regulate the prices of Bt cotton seeds in the State, the government is planning to introduce a Karnataka Cotton Bill, 2014, at the State legislature session to be held in Belagavi in December. The Bill envisages the constitution of an authority headed by the Director of the Agriculture Department for fixation of prices of Bt cotton seeds...

-Down to Earth Pharma company's strategy of different prices for different countries to affect quality treatment of 185 million people infected with Hepatitis C worldwide Health activists and agencies on Tuesday criticised leading pharmaceutical company Bristol-Myers Squibb (BMS)'s commercial strategy to sell new Hepatitis C medicine Daclatasvir, stating it would exclude a large number of patients who cannot afford expensive treatment. BMS had announced that it would create a tiered pricing strategy for...